Alterations in vasoconstrictor responses to the endothelium-derived contracting factor uridine adenosine tetraphosphate are region specific in DOCA-salt hypertensive rats

Pharmacological Research

Volumn 65, Issue 1, 2012, Pages 81-90

  Matsumoto, Takayuki ^a,b   Tostes, Rita C ^c   Webb, R Clinton ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b HOSHI UNIVERSITY   (Japan)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Contraction; Dinucleotide; DOCA salt; EDCF; Extracellular nucleotides; P2 receptor

Indexed keywords

ADENOSINE TRIPHOSPHATE; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; UNCLASSIFIED DRUG; URIDINE ADENOSINE TETRAPHOSPHATE; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CONTROLLED STUDY; HYPERTENSION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; VASCULAR RESISTANCE;

ADENOSINE TRIPHOSPHATE; ANIMALS; AORTA, THORACIC; ARTERIES; BASILAR ARTERY; DESOXYCORTICOSTERONE; DINUCLEOSIDE PHOSPHATES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMORAL ARTERY; HYPERTENSION; MALE; MESENTERIC ARTERIES; PURINERGIC P2 RECEPTOR AGONISTS; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2; SODIUM CHLORIDE, DIETARY; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 84856020288     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2011.09.005     Document Type: Article

References (58)

1. D.F. Bohr, and R.C. Webb Vascular smooth muscle membrane in hypertension Annu. Rev. Pharmacol. Toxicol. 28 1988 389 409
2. M. Feletou, and P.M. Vanhoutte Endothelial dysfunction: a multifaceted disorder Am. J. Physiol. Heart Circ. Physiol. 291 2006 H985 H1002 (Pubitemid 44343640)
3. P.M. Vanhoutte, M. Feletou, and S. Taddei Endothelium-dependent contractions in hypertension Br. J. Pharmacol. 144 2005 449 458 (Pubitemid 40349452)
4. M. Ajay, F.I. Achike, and M.R. Mustafa Modulation of vascular reactivity in normal, hypertensive and diabetic rat aortae by a non-antioxidant flavonoid Pharmacol. Res. 55 2007 385 391 (Pubitemid 46560390)
5. D.L. Lee, R.C. Webb, and L. Jin Hypertension and RhoA/Rho-kinase signaling in the vasculature: highlights from the recent literature Hypertension 44 2004 796 799 (Pubitemid 39577399)
6. S.G. Denniss, A.J. Jeffery, and J.W. Rush RhoA-Rho kinase signaling mediates endothelium- and endoperoxide-dependent contractile activities characteristic of hypertensive vascular dysfunction Am. J. Physiol. Heart Circ. Physiol. 298 2010 H1391 H1405
7. V. Jankowski, M. Tolle, R. Vanholder, G. Schonfelder, M. van der Giet, and L. Henning Uridine adenosine tetraphosphate: a novel endothelium-derived vasoconstrictive factor Nat. Med. 11 2005 223 227 (Pubitemid 40321359)
8. M. Schuchardt, J. Prufer, N. Prufer, A. Wiedon, T. Huang, and M. Chebli The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y(2)-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation J. Mol. Med. 89 2011 799 810
9. A.E. Linder, M. Tumbri, F.F. Linder, R.C. Webb, and R. Leite Uridine adenosine tetraphosphate induces contraction and relaxation in rat aorta Vasc. Pharmacol. 48 2008 202 207
10. Y. Gui, M.P. Walsh, V. Jankowski, J. Jankowski, and X.L. Zheng Up4A stimulates endothelium-independent contraction of isolated rat pulmonary artery Am. J. Physiol. Lung Cell Mol. Physiol. 294 2008 L733 L738 (Pubitemid 351520106)
11. M. Tolle, M. Schuchardt, A. Wiedon, T. Huang, L. Klockel, and J. Jankowski Differential effects of uridine adenosine tetraphosphate on purinoceptors in the rat isolated perfused kidney Br. J. Pharmacol. 161 2010 530 540
12. P.B. Hansen, A. Hristovska, H. Wolff, P. Vanhoutte, B.L. Jensen, and P. Bie Uridine adenosine tetraphosphate affects contractility of mouse aorta and decrease blood pressure in conscious rats and mice Acta Physiol. 200 2010 171 179
13. V. Jankowski, A. Patzak, S. Herget-Rosenthal, T.N. Tran, E.Y. Lai, and T. Gunthner Uridine adenosine tetraphosphate acts as an autocrine hormone affecting glomerular filtration rate J. Mol. Med. 86 2008 333 340
14. M. Malmsjo, M. Hou, W. Pendergast, D. Erlinge, and L. Edvinsson The stable pyrimidines UDPbetaS and UTPgammaS discriminate between contractile cerebrovascular P2 receptors Eur. J. Pharmacol. 458 2003 305 311 (Pubitemid 36009470)
15. Y. Miyagi, S. Kobayashi, J. Nishimura, M. Fukui, and H. Kanaide Dual regulation of cerebrovascular tone by UTP:P2U receptor-mediated contraction and endothelium-dependent relaxation Br. J. Pharmacol. 118 1996 847 856 (Pubitemid 26261253)
16. P.J. Guns, A. Korda, H.M. Crauwels, T. Van Assche, B. Robaye, and J.M. Boeynaems Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta Br. J. Pharmacol. 146 2005 288 295 (Pubitemid 43079969)
17. V. Ralevic, and G. Burnstock Effects of purines and pyrimidines on the rat mesenteric arterial bed Circ. Res. 69 1991 1583 1590
18. S.L. Demel, and J.J. Galligan Impaired purinergic neurotransmission to mesenteric arteries in deoxycorticosterone acetate-salt hypertensive rats Hypertension 52 2008 322 329
19. H.A. Kluess, J.B. Buckwalter, J.J. Hamann, D.S. DeLorey, and P.S. Clifford Frequency and pattern dependence of adrenergic and purinergic vasoconstriction in rat skeletal muscle arteries Exp. Physiol. 91 2006 1051 1058 (Pubitemid 44690817)
20. V. Ralevic, and G. Burnstock Receptors for purines and pyrimidines Pharmocol. Rev. 50 1998 413 492 (Pubitemid 28477681)
21. D. Erlinge, and G. Burnstock P2 receptors in cardiovascular regulation and disease Purinergic Signal 4 2008 1 20
22. G. Burnstock Dual control of vascular tone and remodelling by ATP released from nerves and endothelial cells Pharmacol. Rep. 60 2008 12 20 (Pubitemid 351586538)
23. G. Burnstock Purinergic regulation of vascular tone and remodeling Auton. Autacoid Pharmacol. 29 2009 63 72
24. G. Burnstock The past, present and future of purine nucleotides as signalling molecules Neuropharmacology 36 1997 1127 1139 (Pubitemid 27465601)
25. P.J. Guns, J. Hendrickx, T. Van Assche, P. Fransen, and H. Bult P2Y receptors and atherosclerosis in apolipoprotein E-deficient mice Br. J. Pharmacol. 159 2010 326 336
26. I. Bar, P.J. Guns, J. Metallo, D. Cammarata, F. Wilkin, and J.M. Boeynams Knockout mice reveal a role for P2Y6 receptor in macrophages, endothelial cells, and vascular smooth muscle cells Mol. Pharmacol. 74 2008 777 784
27. T. Matsumoto, R.C. Tostes, and R.C. Webb Uridine adenosine tetraphosphate-induced contraction is increased in renal but not pulmonary arteries from deoxycorticosterone acetate-salt hypertensive rats Am. J. Physiol. Heart Circ. Physiol. 301 2011 H409 H417
28. V. Jankowski, A.A. Meyer, P. Schlattmann, Y. Gui, X.L. Zheng, and I. Stamcou Increased uridine adenosine tetraphosphate contractions in plasma of juvenile hypertensives Arterioscler. Thromb. Vasc. Biol. 27 2007 1776 1781 (Pubitemid 47207173)
29. A.A. Miller, K. Budzyn, and C.G. Sobey Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention Clin. Sci. 119 2010 1 17
30. N. Daneshtalab, and J.S. Smeda Alterations in the modulation of cerebrovascular tone and blood flow by nitric oxide synthase in SHRsp with stroke Cardiovasc. Res. 86 2010 160 168
31. Y. Mori, M. Ohyanagi, S. Koida, A. Ueda, K. Ishiko, and T. Iwasaki Effects of endothelium-derived hyperpolarizing factor and nitric oxide on endothelial function in femoral resistance arteries of spontaneous hypertensive rats Hypertens. Res. 29 2006 187 195
32. N.L. Kanagy, and R.C. Webb Increased responsiveness and decreased expression of G proteins in deoxycorticosterone hypertension Hypertension 27 1996 740 745 (Pubitemid 26086239)
33. F.R. Giachini, J.C. Sullivan, V.V. Lima, F.S. Carneiro, Z.B. Fortes, and D.M. Pollock Extracellular signal-regulated kinase 1/2 activation, via downregulation of mitogen-activated protein kinase phosphatase 1, mediates sex differences in deoxycorticosterone-salt hypertension vascular reactivity Hypertension 55 2010 172 179
34. F.R. Giachini, V.V. Lima, F.S. Carneiro, R.C. Tostes, and R.C. Webb Decreased cGMP level contributes to increased contraction in arteries from hypertensive rats: role of phosphodiesterase 1 Hypertension 57 2011 655 663
35. F.M. Faraci, and D.D. Heistad Regulation of large cerebral arteries and cerebral microvascular pressure Circ. Res. 66 1990 8 17 (Pubitemid 20033921)
36. + channels in the regulation of basilar arterial tone in spontaneously hypertensive rats Clin. Exp. Pharmacol. Physiol. 29 2002 575 581 (Pubitemid 34639329)
37. V.V. Lima, F.R. Giachini, H. Choi, F.S. Carneiro, CarneiroZN, and Z.B. Fortes Impaired vasodilator activity in deoxycorticosterone acetate-salt hypertension is associated with increased protein O-GlucNAcylation Hypertension 53 2009 166 174
38. H.A. Kluess, J.B. Buckwalter, J.J. Hamann, and P.S. Clifford Elevated temperature decreases sensitivity of P2X purinergic receptors in skeletal muscle arteries J. Appl. Physiol. 99 2005 995 998 (Pubitemid 41214514)
39. Z. Ebrahim, D.M. Yellon, and G.F. Baxter Attenuated cardioprotective response to bradykinin, but not classical ischaemic preconditioning, in DOCA-salt hypertensive left ventricular hypertrophy Pharmacol. Res. 55 2007 42 48 (Pubitemid 46108586)
40. R.A. Khalil, and C. Breemen Mechanisms of calcium mobilization and homeostatis in vascular smooth muscle and their relevance to hypertension J.H. Laragh, B.M. Brenner, Hypertesnion: Pathophysiology, Diagnosis and Management 1995 Raven Press New York 523 540
41. M.I. Harhun, O.V. Povstyan, and D.V. Gordienko Purinoceptor-mediated current in myocytes from renal resistance arteries Br. J. Pharmacol. 160 2010 987 997
42. E.W. Inscho, A.K. Cook, R.C. Webb, and L.M. Jin Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter Am. J. Physiol. Renal Physiol. 296 2009 F590 F597
43. C.H. Kim, S.S. Kim, J.Y. Choi, J.H. Shin, J.Y. Kim, and W. Namkung Membrane-specific expression of functional purinergic receptors in normal human nasal epithelial cells Am. J. Physiol. Lung Cell Mol. Physiol. 287 2004 L835 L842 (Pubitemid 39249396)
44. L. Wang, L. Karlsson, S. Moses, A. Hultgardh-Nisson, M. Andersson, and C. Boma P2 receptor expression profiles in human vascular smooth muscle and endothelial cells J. Cardiovasc. Pharmacol. 40 2002 841 853 (Pubitemid 35365082)
45. R.V. Flores, M.G. Hernandez-Perez, E. Aquino, R.C. Garrad, G.A. Weisman, and F.A. Gonzalez Agonist-induced phosphorylation and desensitization of the P2Y2 nucleotide receptor Mol. Cell. Biochem. 280 2005 35 45 (Pubitemid 41829798)
46. M.R. Boarder, and S.M. Hourani The regulation of vascular function by P2 receptors: multiple sites and multiple receptors Trends Pharmacol. Sci. 19 1998 99 107 (Pubitemid 28197811)
47. C.J. Lewis, and R.J. Evans Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels Br. J. Pharmacol. 131 2000 1659 1666 (Pubitemid 32056432)
48. J.R. Gever, D.A. Cockayne, M.P. Dillon, G. Burnstock, and A.P. Ford Pharmacology of P2X channels Pfluger Arch. 452 2006 513 587
49. M. Malmsjo, M. Adner, T.K. Harden, W. Pendergast, L. Edvinsson, and D. Erlinge The stable pyrimidines UDPbetaS and UTPgammaS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery Br. J. Pharmacol. 131 2000 51 56
50. V. Sauzeau, H. Le Jeune, C. Cario-Toumaniantz, N. Vaillant, A.P. Gadeau, and C. Desgranges P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes Am. J. Physiol. Heart Circ. Physiol. 278 2000 H1751 H1761 (Pubitemid 30439184)
51. E.A. Wehrwein, C.A. Northcott, R.D. Loberg, and S.W. Watts Rho/Rho kinase and phosphoinositide 3-kinase are parallel pathways in the development of spontaneous arterial tone in deoxycorticosterone acetate-salt hypertension J. Pharmacol. Exp. Ther. 309 2004 1011 1019 (Pubitemid 38669686)
52. E.G. Delicado, M.T. Miras-Portugal, L.M. Carrasquero, D. Leon, R. Perez-Sen, and J. Gualix Dinucleotide polyphosphates and their interaction with other nucleotide signaling pathways Plfugers Arch. 452 2006 563 572 (Pubitemid 44015091)
53. N.A. Flores, B.M. Stavrou, and D.J. Sheridan The effects of diadenosine polyphosphate on the cardiovascular system Cardiovasc. Res. 42 1999 15 26 (Pubitemid 29167066)
54. M. Yu, V. Gopalakrishnan, and J.R. McNeill Role of endothelin and vasopressin in DOCA-salt hypertension Br. J. Pharmacol. 132 2001 1447 1454 (Pubitemid 32281033)
55. R. Collins, R. Peto, S. MacMahon, P. Hebert, N.H. Fiebach, and K.A. Eberlein Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context Lancet 335 1990 827 838 (Pubitemid 20113741)
56. H. Zimmermann Extracellular metabolism of ATP and other nucleotides Naunyn. Schmiedebergs Arch. Pharmacol. 362 2000 299 309
57. G. Kauffenstein, A. Drouin, N. Thorin-Trescases, H. Bachelard, B. Robaye, and P. D'Orleans-Juste NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse Cardiovasc. Res. 85 2010 204 213
58. G.I. Lunkes, D. Lunkes, F. Stefanello, A. Morsch, V.M. Morsch, and C.M. Mazzanti Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies Thromb. Res. 109 2003 189 194 (Pubitemid 36712907)